PerspectiveMetabolic Disease

Receptor Antibodies as Novel Therapeutics for Diabetes

See allHide authors and affiliations

Science Translational Medicine  14 Dec 2011:
Vol. 3, Issue 113, pp. 113ps47
DOI: 10.1126/scitranslmed.3003447

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Antibodies to receptors can block or mimic hormone action. Taking advantage of receptor isoforms, co-receptors, and other receptor modulating proteins, antibodies and other designer ligands can enhance tissue specificity and provide new approaches to the therapy of diabetes and other diseases.

View Full Text